TY - JOUR
T1 - Oncological and surgical outcomes of pure laparoscopic radical nephrectomy and hand-assisted laparoscopic radical nephrectomy for pT1 renal cell carcinoma
T2 - Comparison with open radical nephrectomy
AU - Kim, Myong
AU - Yong, Hyun Park
AU - Sang, Eun Lee
AU - Kwak, Cheol
AU - Hyeon, Hoe Kim
PY - 2009/5
Y1 - 2009/5
N2 - Purpose: We compared the surgical and oncologic outcomes of pure laparoscopic radical nephrectomy (PLRN) and hand-assisted laparoscopic radical nephrectomy (HLRN) with those of open radical nephrectomy (ORN) in patients with pT1 renal cell carcinoma (RCC). Materials and Methods: Between 1999 and 2007, a total of 269 patients underwent PLRN (n=77), HLRN (n=87), and ORN (n=105) for pT1 RCC. Follow-up data consisted of clinical, pathologic, and oncologic results and were reviewed retrospectively. Kaplan-Meier survival curves were constructed for progression and survival endpoints. Results: Mean operative time was 184.0, 164.0, and 132.6 minutes (p< 0.001); mean estimated blood loss was 196.7, 147.8, and 232.6 ml (p<0.001); and mean postoperative hospital stay was 5.7, 7.2, and 7.8 days (p<0.001) for the PLRN, HLRN and ORN groups, respectively. The major complication rate after surgery was 2.6%, 2.3%, and 3.8%, respectively (p=0.807). Median follow-up periods were 32 months in the PLRN group, 48 months in the HLRN group, and 37 months in the ORN group. Five-year progression-free survival was 97.4%, 96.6%, and 98.1% (p=0.557), and 5-year cancer-specific survival was 98.7%, 96.6%, and 98.1% (p=0.508), respectively. Conclusions: PLRN and HLRN are safe treatment options with comparable oncologic results to ORN for pT1 RCC.
AB - Purpose: We compared the surgical and oncologic outcomes of pure laparoscopic radical nephrectomy (PLRN) and hand-assisted laparoscopic radical nephrectomy (HLRN) with those of open radical nephrectomy (ORN) in patients with pT1 renal cell carcinoma (RCC). Materials and Methods: Between 1999 and 2007, a total of 269 patients underwent PLRN (n=77), HLRN (n=87), and ORN (n=105) for pT1 RCC. Follow-up data consisted of clinical, pathologic, and oncologic results and were reviewed retrospectively. Kaplan-Meier survival curves were constructed for progression and survival endpoints. Results: Mean operative time was 184.0, 164.0, and 132.6 minutes (p< 0.001); mean estimated blood loss was 196.7, 147.8, and 232.6 ml (p<0.001); and mean postoperative hospital stay was 5.7, 7.2, and 7.8 days (p<0.001) for the PLRN, HLRN and ORN groups, respectively. The major complication rate after surgery was 2.6%, 2.3%, and 3.8%, respectively (p=0.807). Median follow-up periods were 32 months in the PLRN group, 48 months in the HLRN group, and 37 months in the ORN group. Five-year progression-free survival was 97.4%, 96.6%, and 98.1% (p=0.557), and 5-year cancer-specific survival was 98.7%, 96.6%, and 98.1% (p=0.508), respectively. Conclusions: PLRN and HLRN are safe treatment options with comparable oncologic results to ORN for pT1 RCC.
KW - Laparoscopic surgery
KW - Nephrectomy
KW - Renal cell carcinoma
KW - Treatment outcome
UR - http://www.scopus.com/inward/record.url?scp=66649132059&partnerID=8YFLogxK
U2 - 10.4111/kju.2009.50.5.457
DO - 10.4111/kju.2009.50.5.457
M3 - Article
AN - SCOPUS:66649132059
SN - 2005-6737
VL - 50
SP - 457
EP - 462
JO - Korean Journal of Urology
JF - Korean Journal of Urology
IS - 5
ER -